We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.05 | 1.00 | 1.10 | 1.0619 | 1.0238 | 1.05 | 2,486 | 08:00:25 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.82 | 1.88M |
From Apr 2019 to Apr 2024
TIDMMSYS
RNS Number : 1753N
Microsaic Systems plc
04 May 2018
4 May 2018
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Result of AGM
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce that all resolutions were duly passed at its Annual General Meeting today.
Enquiries: Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD +44 (0) 1483 751577 N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong +44 (0)20 7496 3000 IFC Advisory Ltd (Financial PR) Graham Herring Heather Armstrong +44 (0)20 3934 6630
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.
Microsaic's core product, the 4500 MiD(R), is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGAIMLTMBJMMLP
(END) Dow Jones Newswires
May 04, 2018 06:25 ET (10:25 GMT)
1 Year Microsaic Systems Chart |
1 Month Microsaic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
